Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Background: The primary aim of this study is to assess, using individual participant data (IPD) meta-analysis, the effects of administration of antenatal magnesium sulphate given to women at risk of preterm birth on important clinical outcomes for their child such as death and neurosensory disability. The secondary aim is to determine whether treatment effects differ depending on important pre-specified participant and treatment characteristics, such as reasons at risk of preterm birth, gestational age, or type, dose and mode of administration of magnesium sulphate.Methods: Discussion: Results are expected to be publicly available in 2012. © 2012 The AMICABLE Group; licensee BioMed Central Ltd.

Original publication

DOI

10.1186/2046-4053-1-21

Type

Journal article

Journal

Systematic Reviews

Publication Date

21/03/2012

Volume

1